Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.772
-0.078 (-4.22%)
At close: Jan 21, 2025, 4:00 PM
1.800
+0.028 (1.58%)
After-hours: Jan 21, 2025, 5:22 PM EST
Adagene Market Cap
Adagene has a market cap or net worth of $78.45 million as of January 21, 2025. Its market cap has decreased by -14.78% in one year.
Market Cap
78.45M
Enterprise Value
3.56M
1-Year Change
-14.78%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $78.45M, a decrease of -90.25%. That is a compound annual growth rate of -44.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 78.45M | -10.95% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |